U.S. Semiconductors Stock News

Meritage Homes stock snapshot Meritage Homes (MTH) has drawn investor attention after a period of steady trading, with the stock recently closing at $68.33. The company reports annual revenue of $5,616.498m and net income of $385.516m. See our latest analysis for Meritage Homes. Recent trading points to gradually improving momentum, with a 7 day share price return of 4.74% and a 30 day share price return of 5.35%, while the 1 year total shareholder return of 9.57% reflects a steadier longer...

Voya Financial stock moves after recent performance shift Voya Financial (VOYA) has drawn fresh attention after a recent performance shift, with the stock showing moves over the past week, month and past 3 months that stand out against its recent history. See our latest analysis for Voya Financial. At a share price of $86.69, Voya Financial’s recent 1-day share price return of 3.28% builds on a 90-day share price return of 28.03%, while the 1-year total shareholder return of 33.25% reflects a...

Regions Financial recently expanded its homeownership support by offering free educational webinars, personalized mortgage guidance, and homebuyer education, while appointing veteran lender Todd Nelson to lead its home improvement financing business. Together with recognition for its treasury and retirement advisory capabilities, these moves highlight Regions’ push to deepen consumer relationships across housing, payments, and workplace retirement services. We’ll examine how Regions’...

In late May 2026, JetBlue announced plans to launch its first-ever nonstop service between Fort Lauderdale and Caracas, Venezuela, and unveiled a new Dominican Republic–themed Airbus A320 livery celebrating its deep ties with Dominican communities. Together with upgraded second-quarter revenue guidance that highlights robust travel demand and operational efficiency, these moves underscore JetBlue’s focus on strengthening Latin American connectivity and customer loyalty. Next, we’ll examine...

In the past few days, commentary on Ingersoll Rand has highlighted that its mission-critical flow creation business has delivered organic revenue growth below industry benchmarks over the last two years, with estimated sales growth of 3.1% for the next 12 months pointing to a potential demand slowdown. An additional concern is the company’s 6.1% return on capital, which raises questions about how effectively management is converting investments into profitable growth opportunities. We’ll now...

The FDA’s recent easing of safety screening requirements for Dianthus Therapeutics (DNTH) claseprubart trials has reshaped the setup for this autoimmune drug candidate, with investors now reassessing timing, risk and potential value in the stock. See our latest analysis for Dianthus Therapeutics. Despite the regulatory tailwind, the stock has recently cooled, with a 7 day share price return down 13.44% and a 30 day share price return down 10.96%. This follows a strong year to date share price...

Walker & Dunlop stock moves after recent performance data Walker & Dunlop (WD) has drawn fresh attention after recent share price moves. The stock is down 12.7% year to date and 21.3% over the past year, despite positive reported annual revenue and net income growth. See our latest analysis for Walker & Dunlop. At a share price of US$51.25, Walker & Dunlop’s recent 7 day share price return of 2.11% contrasts with a year to date share price decline of 12.72%, while the 1 year total shareholder...

Wondering if Altria Group at around US$72.19 is offering fair value or an opening for better returns? This article walks through what the current price really reflects. The stock has returned 3.8% over the last week, 2.9% over the last month, 26.0% year to date, 30.4% over the past year, 101.8% over three years and 114.1% over five years, which gives important context before comparing price to underlying value. Recent coverage has focused on Altria Group's ongoing position in the tobacco...

OPKO Health (NasdaqGS:OPK) has expanded its alliance with Nicoya Therapeutics to advance the commercialization of RAYALDEE in Greater China. The amended agreement gives OPKO an equity interest in Nicoya Therapeutics and a deeper collaborative role in the partnership. The move focuses on driving regulatory progress and commercial preparation for RAYALDEE in a region with significant renal health needs. OPKO Health focuses on diagnostics and pharmaceuticals, with RAYALDEE positioned for...

Sunshine Silver Mining & Refining stock overview Sunshine Silver Mining & Refining (SSMR) drew investor attention after a sharp 18.4% one day share price decline to $14. This move has refocused interest on the company’s fundamentals and current valuation. See our latest analysis for Sunshine Silver Mining & Refining. The sharp 18.4% one-day share price decline comes after a period in which the year-to-date share price return is still 3.7%, so short-term momentum is fading even as the...

Kymera Therapeutics recently presented new clinical findings from its BroADen Phase 1b study of KT-621, an oral STAT6 degrader in development for atopic dermatitis and eosinophilic asthma, alongside its appearance at the Jefferies Global Healthcare Conference 2026 in New York. The data showing strong STAT6 target engagement and biomarker reductions, coupled with fresh analyst coverage highlighting Kymera’s immunology platform, underscore how KT-621 is becoming a focal point in the company’s...

What sparked the latest move in Coastal Financial? Coastal Financial (CCB) has been moving with the wider regional bank group after the Federal Reserve kept interest rates at 3.75%, while a resilient labor market shifted expectations for the timing of future cuts. See our latest analysis for Coastal Financial. At a share price of US$70.24, Coastal Financial has seen its 30 day share price return fall 6.28% and its year to date share price return fall 38.01%, while the 5 year total shareholder...

In the past few days, DaVita reported strong first-quarter 2026 results, with higher revenues, improved earnings and operating income, and raised its full-year adjusted operating income and earnings per share guidance. Beyond the headline beat, DaVita’s willingness to lift guidance while flagging rising patient-care and technology costs highlights management’s confidence in its cost-control and efficiency efforts. Next, we’ll examine how DaVita’s upgraded 2026 earnings guidance could...

RTX stock reacts to Jefferies upgrade and fresh defense contract momentum RTX Corp (RTX) drew fresh attention after Jefferies raised its rating to Buy, highlighting profit margin trends, aerospace engine aftermarket opportunities, and the company’s growing book of defense work, including the recent US$515 million SPY-6 radar contract. See our latest analysis for RTX. Recent momentum has been mixed, with a 2.4% 30 day share price return and a decline of around 13.7% over 90 days. However, a...

Wondering whether Vishay Intertechnology at around US$57.20 still offers value or if the easy gains are gone? This article walks through what the numbers are really saying about the stock. The share price currently sits at US$57.20, with reported returns of 9.9% over 7 days, 70.4% over 30 days, 274.1% year to date and 287.2% over the past year. This naturally raises questions about both opportunity and risk. Recent interest in Vishay Intertechnology has been strong enough to trigger fresh...

In recent days, TE Connectivity highlighted its growing role in AI and high-speed data-center connectivity architectures, while also moving to expand its electrification footprint by acquiring Phoenix Contact E-Mobility’s EV charging inlet business. At the same time, routine insider share sales under pre-arranged Rule 10b5-1 plans underscored that management’s personal trading activity appears separate from the company’s push into AI and EV charging infrastructure. Next, we’ll assess how TE...

GigaCloud Technology (GCT) has drawn fresh attention after being included in TIME's World's Growth Leaders 2026 list and earning multiple American Business Awards tied to revenue growth, global expansion, and product development. See our latest analysis for GigaCloud Technology. Despite recent accolades, GigaCloud Technology’s short term share price momentum has cooled, with the stock down over the past month and quarter, while the 1 year and 3 year total shareholder returns remain strongly...

Zumiez (ZUMZ) opened Q1 2027 with revenue of US$193.3 million and a reported loss of US$13.3 million, or EPS of US$0.82, while trailing twelve month EPS sat at US$0.89. Over the past year, revenue on a trailing basis has moved from US$896.2 million to US$938.1 million, with TTM EPS lifting from US$0.04 to US$0.89 as margins shifted from very thin profitability to a modest 1.5% net margin that puts the latest quarter’s loss into a broader, improving earnings picture. See our full analysis for...

Visa (V) is back in focus after announcing a collaboration with Brale to test stablecoin-based settlement on the privacy-focused Canton Network, alongside upcoming stablecoin platform partnerships with Stripe and Mastercard. See our latest analysis for Visa. The recent Canton Network stablecoin trial and upcoming platform work with Stripe and Mastercard come after a busy period for Visa, with AI enabled commercial tools rolling out and value added services expanding. However, the stock’s 3...

MicroVision (MVIS) has put a reverse stock split proposal at the center of its upcoming 2026 Annual Meeting, asking shareholders to authorize a split in a 1 for 5 to 1 for 15 range. See our latest analysis for MicroVision. The reverse stock split proposal comes after a sharp reset in MicroVision’s share price, which is down 56.11% on a year to date share price return basis and has delivered a 65.75% decline in total shareholder return over the past year. This points to fading momentum as the...

nVent Electric (NVT) is back on investors’ radar after stronger than expected quarterly results and a lift to growth guidance, supported by demand from data center and utility customers. See our latest analysis for nVent Electric. Even after a strong run, with the share price up 53.61% over the past 90 days and the 1 year total shareholder return at 141.34%, recent weakness, including a 1 day share price decline of 6.34% and a softer 1 month share price return of 5.58%, suggests some...

Argan (AGX) has opened Q1 2027 with total revenue of US$291.0 million and basic EPS of US$3.30, against trailing twelve month revenue of US$1.0 billion and EPS of US$11.64 that came with 61.1% year over year earnings growth. Over the last year, the company has seen revenue move from US$874.2 million to US$1.0 billion on a trailing basis, while EPS stepped up from US$6.35 to US$11.64, pointing to a higher earnings contribution on each dollar of sales. With net margins running stronger than a...

In recent days, FactSet Research Systems has drawn attention as investors react to its upcoming fiscal third-quarter 2026 earnings release on 1 July and reassess the company’s positioning in the broader financial data sector. Amid this heightened focus, questions around perceived undervaluation, recent volatility and the lack of recent insider transactions have become central to how the market interprets FactSet’s outlook. We’ll now examine how this increased scrutiny around perceived...

Recent commentary around Merit Medical Systems (MMSI) has zeroed in on valuation, with intrinsic value and discounted cash flow models suggesting the stock may be pricing in a cautious outlook after a challenging year. See our latest analysis for Merit Medical Systems. Merit Medical Systems' recent 1 month share price return of 4.62% comes after a tougher spell, with the 90 day share price return down 11.26% and the 1 year total shareholder return down 32.33%. As a result, recent gains look...